Ohio State Navbar

AACR Meeting To Feature Ohio State Cancer Researchers


COLUMBUS, Ohio – Dr. Michael Caligiuri, director of The Ohio State University Comprehensive Cancer Center and chief executive officer of the James Cancer Hospital and Solove Research Institute, is the program committee’s chairperson for the American Association for Cancer Research (AACR) 100th annual meeting in Denver April 18-22. Caligiuri will preside over the opening plenary session of the meeting, which is expected to attract more than 17,000 cancer scientists worldwide. Twenty-nine scientists and physicians from Ohio State’s cancer program have been invited to speak, chair or moderate sessions during the AACR meeting.

“The past 100 years of cancer research are merely a prelude to the remarkable progress yet to come as scientists continue to make innovative discoveries in the understanding, treatment and prevention of cancer,” says Caligiuri. “This meeting offers cancer researchers the opportunity to keep abreast of these rapidly developing advances.”

The meeting will showcase more than 6,000 papers and hundreds of invited talks from the global community of experts in cancer research. Ohio State cancer researchers participating at the AACR meeting (listed alphabetically) include:

  • Dr. Don Benson, oral presentation, Mini-Symposium: Novel Immunotherapy Targeting Molecular Control of Immune Activation.
  • Dr. Sanford Barsky, oral presentation, New Concepts in Organ Site Research: Inflammatory Breast Cancer: A Global Perspective of Translation from the Laboratory to the Clinic.
  • Dr. Tanios Bekaii-Saab, co-chairperson and oral presentation, New Concepts in Organ Site Research: Recent Advances in Hepatocellular Cancer: From Molecular Profiling to Therapeutics.
  • Dr. John Byrd, invited speaker, Meet-the-Experts Session: Building the Bridge Between the Laboratory and the Clinic for Novel Immunotherapies in Chronic Lymphocytic Leukemia.
  • Ching Shih Chen, co-chairperson, Mini-symposium: Progress and Insights in Combination Chemotherapy.
  • Dr. Carlo Croce, chairperson and oral presentation, Symposium: microRNAs and Human Cancer; discussant, Plenary Session: Spotlight on Breakthroughs in Cancer Research; oral presentation, Mini-symposium: microRNAs/Noncoding RNAs and Cancer.
  • Dr. Albert de la Chapelle, co-chairperson, New Concepts in Organ Site Research: Colon Cancer: Biology, Genetics and Early Detection; oral presentation, Mini-symposium: Cancer Risk Genes: Genome-wide Association Studies and Beyond.
  • Dr. Maura Gillison, co-chairperson and oral presentation, New Concepts in Organ Site Research: Human Papillomavirus and Head and Neck Cancer.
  • Ronald Glaser, mentor, Professional Advancement Session; oral presentation, Symposium: Epigenetic Response to Stress in Determining Health Disparities.
  • Dr. Michael Grever, invited speaker, Forum: Molecular Biology in Early Phase Clinical Trials.
  • Joanna Groden, mentor, Professional Advancement Session: Twelfth Annual Grant Writing Workshop; chairperson, Symposium: How Do Mouse Models of Cancer Inform Clinical Trials?
  • Dr. Nathan Hall, oral presentation, Methods Workshop: Integrating Molecular Imaging with Biomarkers and Functional Measures.
  • Heather L. Hampel, oral presentation, New Concepts in Organ Site Research: Colon Cancer: Biology, Genetics and Early Detection.
  • Dr. Michael Knopp, chairperson, Methods Workshop: Integrating Molecular Imaging with Biomarkers and Functional Measures; moderator, Forums: Assessing Response Using Imaging to Determine Endpoints in Clinical Trials.
  • Pawan Kumar, oral presentation, Mini-symposium: Alterations in the Tumor Microenvironment Effects on Tumor Progression and Metastasis.
  • Dr. Gustavo Leone, co-chairperson, Mini-symposium: Tumor Animal Models.
  • Dr. Young C. Lin, co-chairperson, Mini-symposium: Infectious Agents and Cancer.
  • Dr. Richard Love, co-chairperson and oral presentation, New Concepts in Organ Site Research: Inflammatory Breast Cancer: A Global Perspective of Translation from the Laboratory to the Clinic.
  • Dr. Guido Marcucci, co-chairperson, New Concepts in Organ Site Research: State-of-the-Art Pathophysiology and Therapy of Acute Myeloid Leukemia.
  • Tatiana Oberyszyn, co-chairperson, New Concepts in Organ Site Research: Non-Melanoma Skin Cancer: Thinking Outside of the Box.
  • Dr. Michael Ostrowski, co-chairperson, Mini-symposium: The Tumor Microenvironment: Opportunities for Therapeutic Intervention; chairperson and oral presentation, Mini-symposium: Alterations in the Tumor Microenvironment: Effects on Tumor Progression and Metastasis.
  • Electra Paskett, co-chairperson, Forum: Preparing Junior Investigators for the Future: How to Use Career Development Awards Effectively; invited speaker, Forum: A New Paradigm for Understanding Excess Cancer Risk in Underserved and Minority Populations: The Centers for Population Health and Health Disparities Experience.
  • Dr. Tushar Patel, co-chairperson and oral presentation, New Concepts in Organ Site Research: Recent Advances in Hepatocellular Cancer: From Molecular Profiling to Therapeutics.
  • Dr. Matthew Ringel, co-chairperson, Mini-symposium: Hormones and Cancer.
  • Thomas Schmittgen, oral presentation, Mini-symposium: microRNAs/noncoding RNAs and Cancer.
  • Dr. Manisha Shah, co-chairperson and oral presentation, New Concepts in Organ Site Research: From Experimental Models to Targeted Therapy of Neuroendocrine Tumors.
  • Dr. Miguel Villalona-Calero, co-chairperson, Science Policy Forum: Cancer Drug Development as a Successful Public-Private Enterprise – The NCI Partnership with Industry; co-chairperson, New Concepts in Organ Site Research: The Molecular Biology of Lung Cancer in Never Smokers: A Different Disease; chairperson, Mini-symposium: Clinical Trials.
  • Altaf Wani, chairperson, Mini-symposium: DNA Damage and Cancer.
  • For more information about the AACR annual meeting, visit http://www.aacr.org/home/scientists/meetings--workshops/aacr-100th-annual-meeting-2009.aspx.

    The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute is one of only 40 NCI-designated Comprehensive Cancer Centers in the United States and the only freestanding cancer hospital in the Midwest. Ranked among the top 20 cancer hospitals in the nation, The James is the 172-bed adult patient-care component of the cancer program at The Ohio State University.

    # # #